InvestorsHub Logo
Followers 9
Posts 1092
Boards Moderated 0
Alias Born 08/24/2018

Re: DMC73 post# 103231

Wednesday, 10/03/2018 10:34:25 AM

Wednesday, October 03, 2018 10:34:25 AM

Post# of 191993
Same Answer, speculation. Having been on the side of business, I've come to never count my chickens. I prefer to error on the side of conservative and if things go better than expected, all the better. It's really hard to detach what you hope will happen from what really does, unless they happen to work out congruent.

For example, in the discussion with nFuszed, we are pretty confident that merger will happen and that SC staff will or already have begun offering nFusz product to clients. But they can't force clients to buy if they aren't interested, or simply don't have the budget. Most companies plan yearly budgets, so their purchasing plans can be come very long, where they have to submit requests for purchase approvals as part of the following year's budget. They might be really stoked, but simply don't have funds allocated. It happens sometimes. I've had to prepare budgets, and that's been my experience.

Next we have to estimate how important the nFusz products are to each different client grouping, and the quantity of each grouping. If they are a sales, or medical customer relations, or school customer, their interest might be a surprisingly high number of potential orders. If they are an auto salvage yard, maybe no interest. Creating a matrix to forecast such adoption and penetration can be a work. So when we are guessing overly generalized numbers like 10% - 35% adoption rates, they are mostly gross gut guesses based solely upon experience based instinct. Hope that helps explain the context of my comments.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VERB News